SCHEMBL30897137

SCHEMBL30897137

N#Cc1cccc(Br)c1OCC(CO)CCN=[N+]=[N-]

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28312806 0.73 THRA (0.40) DYRK1A
SCHEMBL27990728 0.70 MAP3K7 (0.40) DYRK1A
SCHEMBL30897136 0.69 — —
SCHEMBL28053434 0.69 AR (0.37) DYRK1A
SCHEMBL24553670 0.68 DYRK1A (0.35) DYRK1A
SCHEMBL29122661 0.66 DYRK1A (0.38) DYRK1A
SCHEMBL25816117 0.65 PTGES (0.35) DYRK1A
SCHEMBL30509819 0.63 EGFR (0.39) DYRK1A
SCHEMBL21143326 0.63 EGFR (0.39) DYRK1A
SCHEMBL1761232 0.62 MAOB (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608808-A1 SOMATOSTATIN RECEPTOR 2 AGONISTS AND USES THEREOF Basecamp Bio Inc. (KY) 2025-09-03 — — EP disclosed
Send feedback